Literature DB >> 4396189

Complications of smallpox vaccination, 1968: results of ten statewide surveys.

J M Lane, F L Ruben, J M Neff, J D Millar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4396189     DOI: 10.1093/infdis/122.4.303

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  55 in total

1.  Uncertain benefit: the public policy of approving smallpox vaccine research.

Authors:  Rosemary B Quigley
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

2.  Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.

Authors:  Douglas W Grosenbach; Robert Jordan; Dennis E Hruby
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

3.  Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Authors:  Joanne Domenico; Joseph J Lucas; Mayumi Fujita; Erwin W Gelfand
Journal:  Int Arch Allergy Immunol       Date:  2012-01-26       Impact factor: 2.749

4.  Laboratory-confirmed transmission of vaccinia virus infection through sexual contact with a military vaccinee.

Authors:  Christina Egan; Cassandra D Kelly; Kim Rush-Wilson; Stephen W Davis; William A Samsonoff; Heidi Pfeiffer; Jim Miller; Jill Taylor; Nick M Cirino
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Comparison of smallpox outbreak control strategies using a spatial metapopulation model.

Authors:  I M Hall; J R Egan; I Barrass; R Gani; S Leach
Journal:  Epidemiol Infect       Date:  2007-01-12       Impact factor: 2.451

6.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.

Authors:  Janice Elaine Y Silverman; Mihai Ciustea; Abigail M Druck Shudofsky; Florent Bender; Robert H Shoemaker; Robert P Ricciardi
Journal:  Antiviral Res       Date:  2008-06-20       Impact factor: 5.970

7.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

8.  Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Authors:  Richard N Greenberg; Edgar Turner Overton; David W Haas; Ian Frank; Mitchell Goldman; Alfred von Krempelhuber; Garth Virgin; Nicole Bädeker; Jens Vollmar; Paul Chaplin
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

Review 9.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

Review 10.  ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.

Authors:  Aysegul Nalca; Elizabeth E Zumbrun
Journal:  Drug Des Devel Ther       Date:  2010-05-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.